Incyte INCB018424 Cream

IRB
CHLA-17-00541
An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
To evaluate the safety and tolerability of INCB018424 cream applied to pediatric subjects with eczema
Study Details
Keywords
atopic dermatitis skin, incb018424
Eligibility
Children ages 2 to 11 years of age with mild to moderate eczema (atopic dermatitis)
Does this study also recruit healthy volunteers?
No
Enrollment Status
Closed
Contact Email
pyong@chla.usc.edu